Connection

Richard Molenkamp to Hepatitis B Surface Antigens

Back to Details
This is a "connection" page, showing publications Richard Molenkamp has written about Hepatitis B Surface Antigens.
Richard Molenkamp
Connection Strength
0.036
Hepatitis B Surface Antigens
  1. Peg-interferon plus nucleotide analogue treatment versus no treatment in patients with chronic hepatitis B with a low viral load: a randomised controlled, open-label trial. Lancet Gastroenterol Hepatol. 2017 08; 2(8):576-584.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.